Sequential deconstruction of composite drug transport in metastatic breast cancer.


Journal

Science advances
ISSN: 2375-2548
Titre abrégé: Sci Adv
Pays: United States
ID NLM: 101653440

Informations de publication

Date de publication:
06 2020
Historique:
received: 08 12 2019
accepted: 12 05 2020
entrez: 9 7 2020
pubmed: 9 7 2020
medline: 12 4 2022
Statut: epublish

Résumé

It is challenging to design effective drug delivery systems (DDS) that target metastatic breast cancers (MBC) because of lack of competent imaging and image analysis protocols that suitably capture the interactions between DDS and metastatic lesions. Here, we integrate high temporal resolution of in vivo whole-body PET-CT, ex vivo whole-organ optical imaging, high spatial resolution of confocal microscopy, and mathematical modeling, to systematically deconstruct the trafficking of injectable nanoparticle generators encapsulated with polymeric doxorubicin (iNPG-pDox) in pulmonary MBC. iNPG-pDox accumulated substantially in metastatic lungs, compared to healthy lungs. Intratumoral distribution and retention of iNPG-pDox varied with lesion size, possibly induced by locally remodeled microenvironment. We further used multiscale imaging and mathematical simulations to provide improved drug delivery strategies for MBC. Our work presents a multidisciplinary translational toolbox to evaluate transport and interactions of DDS within metastases. This knowledge can be recursively applied to rationally design advanced therapies for metastatic cancers.

Identifiants

pubmed: 32637609
doi: 10.1126/sciadv.aba4498
pii: aba4498
pmc: PMC7314527
doi:

Substances chimiques

Doxorubicin 80168379AG

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

eaba4498

Subventions

Organisme : NCI NIH HHS
ID : U54 CA210181
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA193880
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA222959
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA196403
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA213759
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA226537
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA222007
Pays : United States

Informations de copyright

Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC).

Références

Nat Biotechnol. 2015 Sep;33(9):941-51
pubmed: 26348965
Nat Rev Cancer. 2017 Nov;17(11):659-675
pubmed: 29026204
Adv Drug Deliv Rev. 2017 Apr;113:157-176
pubmed: 27521055
Nat Mater. 2016 Nov;15(11):1212-1221
pubmed: 27525571
J Pathol. 2017 Feb;241(3):362-374
pubmed: 27859259
Cardiology. 2010;115(2):155-62
pubmed: 20016174
Biomed Microdevices. 2019 Apr 4;21(2):40
pubmed: 30949850
Mol Imaging. 2011 Feb;10(1):43-55
pubmed: 21303614
J Biomech. 2008 Jul 19;41(10):2312-8
pubmed: 18571181
Sci Rep. 2014 May 02;4:4871
pubmed: 24786000
J Pharmacokinet Pharmacodyn. 2012 Feb;39(1):67-86
pubmed: 22143261
Nat Rev Immunol. 2018 Mar;18(3):168-182
pubmed: 29226910
Nat Nanotechnol. 2008 Mar;3(3):151-7
pubmed: 18654487
Nat Rev Cancer. 2011 Aug 18;11(9):657-70
pubmed: 21850037
Cancer Res. 1988 May 15;48(10):2641-58
pubmed: 3282647
Nature. 2019 Apr;568(7750):117-121
pubmed: 30814728
Nat Rev Cancer. 2006 Jun;6(6):449-58
pubmed: 16723991
Biomaterials. 2011 Jan;32(2):547-55
pubmed: 20880574
Nat Rev Chem. 2017 Aug;1(8):
pubmed: 31286060
Nat Biomed Eng. 2017 Sep;1(9):697-713
pubmed: 31015673
Nat Commun. 2018 Oct 31;9(1):4551
pubmed: 30382084
Nat Rev Clin Oncol. 2016 Nov;13(11):674-690
pubmed: 27184417
ACS Appl Mater Interfaces. 2014 Dec 10;6(23):21677-85
pubmed: 25353068
Trends Biotechnol. 2010 Apr;28(4):181-8
pubmed: 20079548
Biomaterials. 2012 Aug;33(22):5504-13
pubmed: 22579236
Sci Rep. 2013;3:2079
pubmed: 23801070
Nat Biotechnol. 2016 Apr;34(4):414-8
pubmed: 26974511
PLoS Comput Biol. 2016 Jun 10;12(6):e1004969
pubmed: 27286441
Science. 2011 Mar 25;331(6024):1559-64
pubmed: 21436443
Ann Intern Med. 1979 Nov;91(5):710-7
pubmed: 496103
Nat Rev Drug Discov. 2015 Apr;14(4):239-47
pubmed: 25598505
Nat Biotechnol. 2007 Oct;25(10):1165-70
pubmed: 17891134
ACS Nano. 2013 Dec 23;7(12):11174-11182
pubmed: 24187963
Small. 2019 Nov;15(46):e1903747
pubmed: 31565854
Adv Funct Mater. 2012 Oct 23;22(20):4225-4235
pubmed: 23227000
J Control Release. 2012 Feb 28;158(1):148-55
pubmed: 22062689
Compr Physiol. 2012 Jan;2(1):675-709
pubmed: 23606929

Auteurs

Shreya Goel (S)

Department of Nanomedicine, Houston Methodist Research Institute, Houston, TX, USA.

Guodong Zhang (G)

Department of Nanomedicine, Houston Methodist Research Institute, Houston, TX, USA.

Prashant Dogra (P)

Mathematics in Medicine Program, Houston Methodist Research Institute, Houston, TX, USA.

Sara Nizzero (S)

Department of Nanomedicine, Houston Methodist Research Institute, Houston, TX, USA.

Vittorio Cristini (V)

Mathematics in Medicine Program, Houston Methodist Research Institute, Houston, TX, USA.

Zhihui Wang (Z)

Mathematics in Medicine Program, Houston Methodist Research Institute, Houston, TX, USA.

Zhenhua Hu (Z)

Department of Nanomedicine, Houston Methodist Research Institute, Houston, TX, USA.

Zheng Li (Z)

Department of Bioenergetics, Houston Methodist Research Institute, Houston, TX, USA.

Xuewu Liu (X)

Department of Nanomedicine, Houston Methodist Research Institute, Houston, TX, USA.

Haifa Shen (H)

Department of Nanomedicine, Houston Methodist Research Institute, Houston, TX, USA.
Department of Cell and Developmental Biology, Weill Cornell Medical College, New York, NY, USA.

Mauro Ferrari (M)

Department of Nanomedicine, Houston Methodist Research Institute, Houston, TX, USA.
Department of Medicine, Weill Cornell Medical College, New York, NY, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH